Web102 rows · Hims & Hers Health, Inc. (HIMS) NYSE - NYSE Delayed Price. Currency in USD Follow 2W 10W 9M 9.41 -0.28 (-2.89%) At close: 04:00PM EDT 9.61 +0.20 (+2.18%) … WebApr 11, 2024 · According to the issued ratings of 8 analysts in the last year, the consensus rating for Hims & Hers Health stock is Moderate Buy based on the current 2 hold ratings and 6 buy ratings for HIMS. The average twelve-month price prediction for Hims & Hers Health is $11.55 with a high price target of $15.00 and a low price target of $5.00.
Hims Inc. - Hims & Hers Health, Inc. Reports Fourth Quarter and …
Web1 day ago · The analyst firm set a price target for 14.00 expecting HIMS to rise to within 12 months (a possible 40.77 % upside ). 17 analyst firms have reported ratings in the last year. Q Current Stock... WebApr 10, 2024 · Business. The trading price of Hims & Hers Health Inc. (NYSE:HIMS) closed higher on Thursday, April 06, closing at $9.95, 1.84% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $9.76 and $9.97. In examining the 52-week price action we see that the stock hit a 52 ... script not executing html onload
Hims & Hers Health Stock (NYSE:HIMS), Quotes and News Summary
WebApr 10, 2024 · Apr 10, 2024, 2:00 AM. Andrew Dudum, a cofounder and the CEO of Hims & Hers. Hims. '. As startups dive into prescribing hot new weight loss drugs, Hims & Hers is taking a backseat. Its CEO said ... WebApr 12, 2024 · Hims & Hers Health, Inc. (NYSE:HIMS – Get Rating) shares traded down 2.7% on Tuesday following insider selling activity.The stock traded as low as $9.52 and … WebApr 6, 2024 · Hims & Hers Health last issued its earnings results on February 27th, 2024. The reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.02. The company had revenue of $167.30 million for the quarter, compared to the consensus estimate of $161.18 million. payton and jones wines